喜炎平联合阿洛西林治疗急性上呼吸道感染的研究
Investigation of Xiyanping and Azlocillin in Treating Acute Upper Respiratory Tract Infection

作者: 乔 进 * , 冯艳 , 陆群 :南通市第三人民医院药剂科,南通;

关键词: 喜炎平注射液利巴韦林急性上呼吸道感染Xiyanping Injection Ribovirin Acute Upper Respiratory Tract Infection

摘要:

目的:探讨喜炎平注射液治疗急性上呼吸道感染的安全性和临床疗效。方法:150例急性上呼吸道感染患者随机分为治疗组和对照组,各75例。治疗组给予喜炎平注射液150 mg静滴,每日1次;对照组给予利巴韦林注射液500 mg静滴,每日1次。两组均加阿洛西林2 g静滴,每日1次。对比两组治疗3天后的临床效果。结果:治疗3天后,治疗组总有效率96%,对照组总有效率84%,治愈率分别为87%和68%,两组总有效率及治愈率均有显著差异(P < 0.01),治疗组在临床症状改善和见效时间两方面均明显优于对照组(P < 0.05)。治疗组未见明显的不良反应。结论:喜炎平注射液联合阿洛西林能明显缓解急性上呼吸道感染症状,无明显不良作用,是治疗急性上呼吸道感染较理想的药物。

Abstract: Objective: To explore the safety and clinical effect of Xiyanping Injection on acute upper respiratory tract infection. Methods: To divide 150 cases into treatment group and control group randomly, 75 in each group. The treat- ment group was given Xiyanping Injection 150 mg by intravenous drip, once daily. The control group was given Ribo- virin Injection 500 mg by intravenous drip, once daily. Both groups were injected with azlocillin 2 g intravenously, once daily. The clinical effects after 3 days treatment were compared between the two groups. Results: After 3 days treat- ment, the total effective rate of the therapeutic group was 96%, and that of the control group was 84%. The curative rates were 87% and 68% respectively. The diferences of total effective rates and curative rates between the two groups were significant (P < 0.01). And the relief of symptoms of the therapeutic group was significantly different from that of the control group (P < 0.05). Compared with the control group, the therapeutic group had minor adverse reactions. Conclusion: Xiyanping Injection with azlocillin can significantly relieve the symptoms of acute upper respiratory tract infection without obvious toxic and adverse effect. It is a favorable medicine for the treatment of acute upper respiratory tract infection.

文章引用: 乔 进 , 冯艳 , 陆群 (2013) 喜炎平联合阿洛西林治疗急性上呼吸道感染的研究。 药物资讯, 2, 1-3. doi: 10.12677/PI.2013.21001

参考文献

[1] 王水利, 罗小峰, 赵岚等. 12年来呼吸道感染病原菌回顾调查[J]. 中华医院感染学杂志, 2006, 16(7): 828-830.

[2] 陈灏珠. 实用内科学(11版)[M]. 北京: 人民卫生出版社, 2001: 301-304.

[3] 孙法兴. 临床疾病诊断依据治愈好转标准[M]. 北京: 人民军医出版社, 1998: 169-269.

[4] 王水利, 罗小峰, 赵岚等. 12年来呼吸道感染病原菌回顾调查[J]. 中华医院感染学杂志, 2006, 16(7): 828-830.

[5] 余洋, 丛艳, 权晓丹等. 注射用喜炎平药效学研究[J]. 辽宁中医药大学学报, 2009, 7(11): 198-200.

[6] 陈海平. 喜炎平注射液佐治婴幼儿肺炎100例疗效观察[J]. 南京医科大学学报, 2007, 27(3): 280-281.

[7] 袁晓静. 注射用喜炎平[J]. 齐鲁药事, 2006, 25(7): 445.

[8] 王艳, 李秋元, 陈建军等. 阿洛西林钠盐的制备[J]. 中国抗生素杂志, 2006, 31(1): 49.

[9] 王继红. 阿洛西林钠临床应用情况[J]. 现代中西医结合杂志, 2009, 5(13): 1571.

分享
Top